SCHEMBL19862812

SCHEMBL19862812

c1ccc(N(c2ccccc2)c2cc3c4ccccc4oc3c3c2c2ccccc2n3-c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 4/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 2/20 0.36
TSHR P16473 2/20 0.36
KMT2A Q03164 2/20 0.36
HSD17B10 Q99714 2/20 0.36
BRCA1 P38398 1/20 0.36
PPARG P37231 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NR2E3 Q9Y5X4 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
LMNA P02545 2/20 0.33
AHR P35869 1/20 0.33
CA12 O43570 2/20 0.32
CA9 Q16790 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HCRTR1 O43613 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862796 0.94 ALDH1A1 (0.33) KDM4EATML3MBTL1ALDH1A1POLB
SCHEMBL19862814 0.94 ALDH1A1 (0.33) KDM4EATML3MBTL1ALDH1A1POLB
SCHEMBL21707366 0.94 ALDH1A1 (0.33) KDM4EATML3MBTL1ALDH1A1POLB
SCHEMBL18593680 0.93 ALDH1A1 (0.32) KDM4EATML3MBTL1ALDH1A1POLB
SCHEMBL19862809 0.92 ALDH1A1 (0.31) KDM4EATML3MBTL1ALDH1A1POLB
SCHEMBL19862818 0.92 ALDH1A1 (0.31) KDM4EATML3MBTL1ALDH1A1POLB
SCHEMBL18594242 0.91 ALDH1A1 (0.32) KDM4EATML3MBTL1ALDH1A1POLB
SCHEMBL19862813 0.89 NPC1 (0.31)
SCHEMBL24518981 0.88 MEN1 (0.30) ALDH1A1POLBMEN1TSHRKMT2A
SCHEMBL19862810 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 KDM4E 1039/4885ATM 2081/4885L3MBTL1 622/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 KDM4E 1039/4885ATM 2081/4885L3MBTL1 622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.